FINWIRES · TerminalLIVE
FINWIRES

Leerink Partners Upgrades Gossamer Bio to Outperform From Market Perform, $1 Price Target

By

Gossamer Bio (GOSS) has an average rating of overweight and mean price target of $3.86, according to analysts polled by FactSet.

What else is happening in Research?